Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,253,000
-
Total 13F shares
-
25,179,256
-
Share change
-
-275,386
-
Total reported value
-
$218,799,542
-
Price per share
-
$8.69
-
Number of holders
-
83
-
Value change
-
-$4,613,214
-
Number of buys
-
37
-
Number of sells
-
43
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q1 2020
As of 31 Mar 2020,
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,179,256 shares.
The largest 10 holders included
WYNNEFIELD CAPITAL INC, Russell Investments Group, Ltd., DIMENSIONAL FUND ADVISORS LP, Legion Partners Asset Management, LLC, BlackRock Inc., NWQ INVESTMENT MANAGEMENT COMPANY, LLC, HEARTLAND ADVISORS INC, INVESTMENT COUNSELORS OF MARYLAND LLC, Walthausen & Co., LLC, and STATE STREET CORP.
This page lists
83
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.